MOLECULAR PCR TESTING - THIRD PARTY RT-PCR CONTROLS

Thanks to its partnership with Qnostics, Randox allows expands its range of true third party controls to molecular infectious disease testing
Qnostics  has developed, in response to the current Coronavirus outbreak, a range of products designed to support the validation, verification and performance monitoring of molecular assays used in the testing of SARS-CoV-2 (COVID-19).
Accurate and reliable laboratory testing is an essential aspect of COVID-19 disease management and outbreak control. The use of third-party controls will allow laboratories to effectively monitor the performance of diagnostic methods.